|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2003-3-25
|
|
pubmed:abstractText |
Neoadjuvant chemotherapy for patients with muscle-invasive bladder carcinoma is given to treat micrometastases and to preserve the bladder. The objective of this study was to evaluate the possibility of bladder preservation in patients with muscle-invasive bladder carcinoma who were treated with neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) chemotherapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
pubmed-author:AminiMostafàM,
pubmed-author:CalabròFabioF,
pubmed-author:De CarliPieroP,
pubmed-author:De PaulaFrancescoF,
pubmed-author:EmiliozziPaoloP,
pubmed-author:GiannarelliDianaD,
pubmed-author:PansadoroVitoV,
pubmed-author:PizzoMaurizioM,
pubmed-author:PlataniaAndreaA,
pubmed-author:ScarponePaoloP,
pubmed-author:SchnetzerSylviaS,
pubmed-author:SternbergCora NCN
|
|
pubmed:copyrightInfo |
Copyright 2003 American Cancer Society.DOI 10.1002/cncr.11232
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
97
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1644-52
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12655521-Adult,
pubmed-meshheading:12655521-Age Factors,
pubmed-meshheading:12655521-Aged,
pubmed-meshheading:12655521-Aged, 80 and over,
pubmed-meshheading:12655521-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:12655521-Carcinoma,
pubmed-meshheading:12655521-Chemotherapy, Adjuvant,
pubmed-meshheading:12655521-Cisplatin,
pubmed-meshheading:12655521-Doxorubicin,
pubmed-meshheading:12655521-Female,
pubmed-meshheading:12655521-Humans,
pubmed-meshheading:12655521-Male,
pubmed-meshheading:12655521-Methotrexate,
pubmed-meshheading:12655521-Middle Aged,
pubmed-meshheading:12655521-Neoadjuvant Therapy,
pubmed-meshheading:12655521-Neoplasm Invasiveness,
pubmed-meshheading:12655521-Patient Selection,
pubmed-meshheading:12655521-Urinary Bladder Neoplasms,
pubmed-meshheading:12655521-Vinblastine
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Can patient selection for bladder preservation be based on response to chemotherapy?
|
|
pubmed:affiliation |
Vincenzo Pansadoro Foundation, Rome, Italy. cstern@mclink.it
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
